INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
![global communications, global business and transport communications-GettyImages-922750892]( "What Global Survey Says About Scant Patient Access To CAR-T Therapy")
What Global Survey Says About Scant Patient Access To CAR-T TherapyThe Worldwide Network for Blood and Marrow Transplantation initiated a survey to understand cost, infrastructure, and regulatory differences affecting access.
-
![GettyImages-1441381006 budget talks]( "Precision Project Management In Action")
Precision Project Management In ActionDiscover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).
-
![GettyImages-107698014_DMD wheelchair]( "Huntington's Disease Clinical Trials: Innovation, Challenges, And The Road Ahead")
Huntington's Disease Clinical Trials: Innovation, Challenges, And The Road AheadThe Huntington’s disease (HD) landscape is undergoing rapid transformation driven by breakthroughs in gene-targeted therapies, small-molecule modulators, regenerative medicine, and digital innovation.
-
![AI technology-GettyImages-2196492370]( "Leveraging AI To Transform Neurodegenerative Drug Development")
Leveraging AI To Transform Neurodegenerative Drug DevelopmentExplore how AI is redefining the development pipeline for neurodegenerative diseases (NDDs), offering a path forward in the quest for effective, disease-modifying treatments.
-
![Business Partners Negotiating Deal-GettyImages-1424912318]( "How Strategic Resourcing Accelerates Biotech's Path From Preclinical To FIH")
How Strategic Resourcing Accelerates Biotech's Path From Preclinical To FIHExplore how strategic resourcing, particularly through FSP models, empowers biotech sponsors to overcome common hurdles transitioning when from preclinical research to first-in-human (FIH) trials.
-
![Gene therapy iStock-1300754583]( "ThinkLive Cell and Gene Therapy Summit 2025 Summary")
ThinkLive Cell and Gene Therapy Summit 2025 SummaryFrom patient support to intricate logistics, ThinkLive CGT Summit 2025 leaders tackled the essential commercial strategies needed to deliver these innovative therapies to patients globally.
-
![patient recruitment iStock-1299220556]( "Effective Recruitment Capabilities And Outstanding Customer Service")
Effective Recruitment Capabilities And Outstanding Customer ServiceHear from many customers who commend OpenClinica's effective recruitment capabilities, outstanding customer service, and adept problem resolution.
-
![GettyImages-1371925389-lab-scientist-collaboration-computer-clipboard]( "Optimizing Clinical Data: Reducing Redundancy For Efficiency")
Optimizing Clinical Data: Reducing Redundancy For EfficiencyEnabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.
-
![GettyImages-1420679447]( "The Hidden Risk In Cell & Gene Therapy Commercialization")
The Hidden Risk In Cell & Gene Therapy CommercializationOf the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.
-
![audit, electronic certification, analysis-GettyImages-2184117272]( "Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EU")
Everything To Know About Long-Term Data Collection For Cell And Gene Therapy Trials In The EUDiscover how to secure uninterrupted access to long-term trial data for CAR-T therapies by participating in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T Data Collection Initiative.
